Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.


Extracellular Vesicles in Health and Disease

Extracellular Vesicles in Health and Disease
Reported by
Pinelopi Kyriazi

Posted April 23, 2019

Pinelopi Kyriazi is a PhD candidate in neuroscience and a science writer in New York.

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences


Released by nearly all cell types in the human body, Extracellular Vesicles (EVs) are small lipid-encapsulated vesicles that contain molecular cargo such as proteins, lipids, miRNAs, and DNA. Though previously reduced to simple carriers of cellular debris, EVs have emerged as critical players in cell signaling and biomarker discovery. The ease of isolating EVs through non-invasive liquid biopsies has made them a promising tool for diagnostics throughout disease progression. They have also gained traction as therapeutics due to their tissue-specific targeting and ability to deliver therapeutic proteins undetected by the immune system.

Find out more about the latest in diagnostic and therapeutic applications of extracellular vesicles (EVs) in this summary of our February 19, 2019, symposium on the topic.

Symposium Highlights

  • EVs play an important role in signaling cancer metastasis and proliferation.
  • Exosomes extracted from stem cells contain therapeutic cargo that protects against cardiovascular disease.
  • Individual differences in protein expression and tissue targeting of EVs can be used to identify different types of cancer and signal disease progression.
  • Macrophage-extracted EVs can be loaded with therapeutic proteins and delivered to the brain by crossing the blood-brain barrier undetected.
Keynote Address
Session 1: The Role of Exosome Biology in Pathway Regulation
Session 3: Exosomes as Biomarkers and Therapeutics